DeepIntent vs Doximity

OptimizeRx Partners with The Trade Desk for Programmatic

OptimizeRx, a healthcare marketing technology company providing software subscriptions for drug-prescribing and record-keeping systems, is expanding into programmatic advertising. After an earlier partnership with healthcare-focused DSP DeepIntent, the company has now integrated with The Trade Desk. This move allows advertisers to target healthcare providers (HCPs) within electronic health records (EHRs) at the point of care. Targeting uses National Provider Identifiers (NPIs), ensuring precise, bot-free, fully viewable ad placements. OptimizeRx aims to maintain strict ad creative vetting to avoid misleading doctors. The partnership also opens opportunities for non-prescription brands, such as OTC products, to reach specific doctors based on geography and season. Over 99% of OptimizeRx's current ad business is tied to prescription drugs, but programmatic offers new revenue streams.

• OptimizeRx has entered a new programmatic partnership with The Trade Desk.
• The company previously partnered with healthcare DSP DeepIntent earlier this year.
• OptimizeRx's ad inventory is within HCP electronic health records (EHRs) at the point of care.

DeepIntent Launches Cora, the First Fully Agentic Marketing Platform for Healthcare

DeepIntent announced the launch of Cora, described as the first fully agentic marketing platform for healthcare, marking a significant product introduction.

DeepIntent launches agentic ad platform Cora for pharma marketing

DeepIntent, a healthcare-focused adtech firm, has launched Cora, an AI-powered agentic advertising platform designed for pharmaceutical marketers. The platform uses multiple AI agents to handle campaign planning, audience strategy, and media execution, including linear TV via a VideoAmp integration. Cora aims to speed up marketing workflows, with beta tests showing a 50% reduction in planning cycles and over 95% of clients reporting faster processes. This launch follows DeepIntent's majority stake sale to Vitruvian Partners, which provided $637 million to develop AI tools. The company targets the growing complexity of pharma marketing, especially for niche drugs targeting small patient populations. Cora is also powered by Helix, a data application providing aggregated healthcare data, including payer signals and drug coverage insights.

• DeepIntent launched Cora, an agentic ad platform for pharma marketing.
• Cora uses AI agents for campaign planning, audience targeting, and execution.
• Cora integrates with VideoAmp for linear TV campaign execution.

Doximity Faces Securities Fraud Class Action Lawsuit

Schall, Brown & Schwartz LLP (SBS) has announced a class action lawsuit against Doximity, Inc. (NYSE: DOCS) for alleged violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. The complaint claims Doximity made false and misleading statements, overstating the positive impact of its Newsfeed product on revenue growth and misleading investors about its advertising delivery methods, which included banner ads and newsletters. The class period is from August 8, 2024, to May 13, 2026, with a deadline of November 16, 2026, for investors to seek lead plaintiff appointment. Investors who purchased shares during this period may be eligible for recovery.

• SBS files class action lawsuit against Doximity for securities fraud violations.
• Class period: August 8, 2024 to May 13, 2026.
• Deadline for lead plaintiff appointment: November 16, 2026.

Novant Health Partners with Doximity to Bring Evidence-Based Clinical AI Into Epic

Doximity announces new partnerships with Novant Health and Penn Highlands Healthcare to deploy its Clinical AI Suite, and releases the 2026 Physician Compensation Report highlighting AI fluency as a career advantage.

Penn Highlands Healthcare Partners with Doximity to Launch System-Wide Clinical AI Suite

Doximity announces a partnership with Penn Highlands Healthcare to deploy its Clinical AI Suite system-wide.